Furthermore, L1CAM, CDKN1C, and FEN1, which have been reported to be relevant to breast cancer – the most sensitive subtype to docetaxel among the nine NCI-60 cancer subtypes – were clustered just next to the drug vector. Here, FEN1 is linked to breast carcinoma.